These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3976516)

  • 41. Comparison of the effects of urapidil and nitroprusside on hemodynamics and myocardial function in hypertension following cardiac surgery.
    Van der Stroom JG; Van Wezel HB; Koolen JJ; Visser CA; Van Zwieten PA
    Blood Press Suppl; 1994; 4():31-8. PubMed ID: 7804510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systemic and renal hemodynamic changes after two-month treatment with enalapril in patients with essential hypertension.
    Valvo E; Gammaro L; Bedogna V; Tonon M; Giorgetti P; Pica B; Antonini P; Tessitore N; Oldrizzi L; Rugiu C
    Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):656-9. PubMed ID: 2830196
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
    Lund-Johansen P; Omvik P; Nordrehaug JE; White W
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cardiovascular effects of urapidil].
    Bousquet P; Decker N; Feldman J; Schwartz J
    J Pharmacol; 1983; 14(4):465-72. PubMed ID: 6672466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hemodynamic modifications induced by urapidil in man].
    Bielen E; Fagard R; Lijnen P; M'Buyamba-Kabangu JR; Staessen J; Van Hoof R; Amery A
    Therapie; 1990; 45 Suppl 2():191-7. PubMed ID: 2187267
    [No Abstract]   [Full Text] [Related]  

  • 46. Immediate and short-term cardiovascular effects of a new converting enzyme inhibitor (lisinopril) in essential hypertension.
    Garavaglia GE; Messerli FH; Nunez BD; Schmieder RE; Frohlich ED
    Am J Cardiol; 1988 Nov; 62(13):912-6. PubMed ID: 2845768
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Candesartan cilexetil and renal hemodynamics in hypertensive patients.
    Fridman K; Wysocki M; Friberg P; Andersson OK
    Am J Hypertens; 2000 Sep; 13(9):1045-8. PubMed ID: 10981559
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The treatment of intraoperative arterial hypertension with Urapidil].
    Filosso PL
    Minerva Cardioangiol; 1996 Apr; 44(4):197-207. PubMed ID: 8767601
    [No Abstract]   [Full Text] [Related]  

  • 49. Control of hypertension during cardiopulmonary bypass with urapidil and phentolamine.
    Göb E; Barankay A; Richter JA
    Arzneimittelforschung; 1981; 31(9):1479-81. PubMed ID: 7197959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiac and circulatory response to the intravenous administration of urapidil during general anaesthesia.
    Fontana F; Allaria B; Brunetti B; Arienta R; Favaro M; Trivellato A; Rusconi MG
    Drugs Exp Clin Res; 1990; 16(6):315-8. PubMed ID: 2086167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hemodynamic effects of different antihypertensive combinations].
    Wiechmann HW
    Dtsch Med Wochenschr; 1988 Jun; 113(25):1007-12. PubMed ID: 3289874
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of the angiotensin type I receptor antagonist, losartan, on systemic and regional vascular responses to lower body negative pressure in healthy volunteers.
    Duranteau J; Pussard E; Berdeaux A; Giudicelli JF
    Br J Clin Pharmacol; 1995 Nov; 40(5):431-8. PubMed ID: 8703646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic and renal hemodynamic effects of celiprolol in essential hypertensives.
    Lucarini AR; Salvetti A
    Am J Cardiol; 1988 Feb; 61(5):45C-48C. PubMed ID: 2963525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hemodynamic and metabolic effects of intravenous clentiazem in hypertensive patients.
    Frohlich ED; McLoughlin M; Ketelhut R
    Am J Cardiol; 1992 Jan; 69(3):229-32. PubMed ID: 1731463
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and Safety of Intravenous Urapidil for Older Hypertensive Patients with Acute Heart Failure: A Multicenter Randomized Controlled Trial.
    Yang W; Zhou YJ; Fu Y; Qin J; Qin S; Chen XM; Guo JC; Wang Z; Zhan H; Li J; He JY; Hua Q
    Yonsei Med J; 2017 Jan; 58(1):105-113. PubMed ID: 27873502
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiovascular risks and benefits of perioperative nonsteroidal anti-inflammatory drug treatment.
    Camu F; Van Lersberghe C; Lauwers MH
    Drugs; 1992; 44 Suppl 5():42-51. PubMed ID: 1284561
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systemic and renal hemodynamic effects of bupicomide: a new vasodilator.
    Chrysant SG; Adamopoulos P; Tsuchiya M; Frohlich ED
    Am Heart J; 1976 Sep; 92(3):335-9. PubMed ID: 782220
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neural control of circulation before and after intravenous urapidil in essential hypertension.
    Grassi G; Parati G; Pomidossi G; Giannattasio G; Casadei R; Groppelli A; Zanchetti A; Mancia G
    Drugs; 1988; 35 Suppl 6():104-10. PubMed ID: 3402353
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autonomic, systemic, and renal hemodynamic actions of trimazosin in hypertensive patients.
    Chrysant SG
    Am Heart J; 1983 Nov; 106(5 Pt 2):1243-50. PubMed ID: 6356852
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
    Sánchez RA; Marcó E; Gilbert HB; Raffaele P; Brito M; Giménez M; Moledo LI
    Drugs; 1985; 30 Suppl 1():49-58. PubMed ID: 2994987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.